Part,  Chapter, Paragraph

  1    I,     2.  5       |     employment from 66 per cent in 1995 to 71 per cent in 2005 in
  2    I,     2. 10.  3   |        adaptation (Freeman, et al, 1995) 7.The process of structural
  3    I,     2. 10.  3(7)|             Soete L, Efendioglu U (1995): Diffusion and the employment
  4    I,     2. 11       |             Soete L, Efendioglu U (1995): Diffusion and the employment
  5    I,     3.  1       |           from 2.51 to 1.25 (1963- 1995). Fertility decline was
  6    I,     3.  1       |          than for women (Toulemon, 1995). Research shows that having
  7    I,     3.  4       |            231-251.~ ~Toulemon, L (1995): The Place of Children
  8   II,     4.  1       |            ECHP) study run between 1995 and 2001. Relevant questions
  9   II,     4.  1       |  disabilities.~ ~LE estimates from 1995 to 2005 for the 27 current
 10   II,     4.  1       |         DFLE65 /LE65 computed from 1995 to 2001 with the ECHP survey.~ ~
 11   II,     4.  1       |      consider a gain of 5% between 1995 and 2001 to signify compression
 12   II,     4.  1       |        European Union (EU27), from 1995 to 2005, per gender~ ~Over
 13   II,     4.  1       |            Over the 10 year period 1995-2005, life expectancy at
 14   II,     4.  1       |          gaps between the MS since 1995.~ ~Table 4.1.4. Minimum
 15   II,     4.  1       |         the EU27, USA and Japan in 1995 and in 2005 and by gender.
 16   II,     4.  1       |      America (USA) and in Japan in 1995 and 2005, per gender~ ~Table
 17   II,     4.  1       |            over the 10-year period 1995-2005 and the second largest (
 18   II,     4.  3       |           the European Union since 1995: similarities and differences
 19   II,     5.  2.  4   |          surveys were conducted in 1995-96, 1999-2000 and 2005-6
 20   II,     5.  3.  6   |          presents survival data in 1995-1999 and 2000-2002. In this
 21   II,     5.  3.  6   |              Patients diagnosed in 1995-1999~Berrino et al (2007)
 22   II,     5.  3.  6   |       cases that were diagnosed in 199599 and followed up to December,
 23   II,     5.  3.  6   |         TNEH. Data for 199094 and 199599 showed a survival increase
 24   II,     5.  3.  9   |       European adults diagnosed in 199599: results of the EUROCARE-4
 25   II,     5.  4.  2   |             2002; Azzopardi et al. 1995; Beck et al. 2001), or by
 26   II,     5.  4.  8   |       Mazovetsky A, Olchanski V., (1995) A computerized health screening
 27   II,     5.  4.  8   |     diabetes mellitus, Diabet Med. 1995 Mar;12(3):271-6~Beck, P,
 28   II,     5.  4.  8   |         Global burden of diabetes, 1995-2025: prevalence, numerical
 29   II,     5.  5.  1   |        standardized death rate) in 1995 and 2005 in the EU. Source:
 30   II,     5.  5.  3   |          Misra et al, 2004; Gupta, 1995). Anorexia is a psychological
 31   II,     5.  5.  3   |            and young women (Gupta, 1995). Young girls and boys follow
 32   II,     5.  5.  3   |      potential infertility (Gupta, 1995). Therefore, an early diagnosis
 33   II,     5.  5.  3   |            March 2008).~Gupta M A (1995): Concerns About Aging and
 34   II,     5.  5.  3   |        exception (Cockerell et al, 1995), the incidence of epilepsy
 35   II,     5.  5.  3   |            study (Cockerell et al, 1995) age-specific incidence
 36   II,     5.  5.  3   |   incidence studies (Nashef et al, 1995). The patient at risk for
 37   II,     5.  5.  3   |           of age (Cockerell et al, 1995). The 5-year remission rate
 38   II,     5.  5.  3   |        seriously behind (Thompson, 1995). Studies made in Finland
 39   II,     5.  5.  3   |            I, Goodridge DM, et al (1995): Epilepsy in a population
 40   II,     5.  5.  3   |          Fish DR, Garner S, et al (1995): Sudden death in epilepsy :
 41   II,     5.  5.  3   |          41:998-1004.~Thompson PJ (1995): The impact of epilepsy
 42   II,     5.  5.  3   |         Sudomoina M, Turetskaya R (1995): Epidemiology of multiple
 43   II,     5.  5.  3   |            prevalence on 1 January 1995 and incidence over a 25-
 44   II,     5.  5.  3   |      prevalence and incidence 1993-1995. Neurol Neurochir Pol 33:
 45   II,     5.  5.  3   |            Fraser M, Compston DAS (1995): multiple sclerosis in
 46   II,     5.  5.  3   |           al, 2002; de Rijk et al, 1995; Granieri et al, 1991; Schrag
 47   II,     5.  5.  3   |       department of statistics in, 1995 (Bundesministerium für Gesundheit,
 48   II,     5.  5.  3   |  Bundesministerium für Gesundheit, 1995). PD patients retired at
 49   II,     5.  5.  3   |           due to PD (Clarke et al, 1995).~ ~
 50   II,     5.  5.  3   | Bundesministerium für Gesundheit., 1995. Daten des Gesundheitswesen.
 51   II,     5.  5.  3   |            Zobkiw RM, Gullaksen E (1995): Quality of life and care
 52   II,     5.  5.  3   |            der Meche FG, Hofman A (1995): Prevalence of Parkinson’
 53   II,     5.  6.  3   |      previous year ( Natvig et al, 1995). They were the most common
 54   II,     5.  6.  3   |       occur spontaneously (Melton, 1995).~ ~Table 5.6.8. Risk Factors
 55   II,     5.  6.  3   |           density (Cummings et al, 1995) can identify those at much
 56   II,     5.  6.  4   |  respiratory disorders (Stansfeld, 1995). Musculoskeletal complaints
 57   II,     5.  6.  6   |        Cauley J, Black D, Vogt TM (1995): Risk factors for hip fracture
 58   II,     5.  6.  6   |            111-115~Melton LJ, III (1995): Epidemiology of fractures.
 59   II,     5.  6.  6   |             Bruusgaard D, Rutle O (1995): Musculoskeletal symptoms
 60   II,     5.  6.  6   |             Cirillo PA, Walker AM (1995): Incidence of symptomatic
 61   II,     5.  6.  6   |       Canner R, North F, Marmot M (1995): Sickness absence for psychiatric
 62   II,     5.  7.  3   |         1990-1994) and 12% (cohort 1995-1999) lower risk of death.
 63   II,     5.  8.  4   |            gender (Siafakas et al, 1995). But a study by Soriano
 64   II,     5.  9.  3   |       seems to have decreased from 1995 until 2005 (-52%) (Tuberkulóza
 65   II,     5.  9.  7   |         olds in the British Isles, 1995-2002: Questionnaire survey.
 66   II,     5. 10.  2   |            and other cereals (SCF, 1995).~ ~
 67   II,     5. 10.  7   |         Committee for Foods (SCF) (1995): Report on adverse reactions
 68   II,     5. 11.  3   |      supervision) (Williams et al, 1995). Prevalence estimates for
 69   II,     5. 11.  3   |     community survey (Neame et al, 1995).~Although there are no
 70   II,     5. 11.  3   |          13 to 39% during the 19851995 period (L Mattila et al.
 71   II,     5. 11.  3   |           in Finland, in the years 199597 and 200002 the patch
 72   II,     5. 11.  3   |           to cosmetic allergens in 19951997 and 20002002 in Finland –
 73   II,     5. 11.  3   |     Finnish university students in 1995, Contact Dermatitis, 2001;
 74   II,     5. 11.  3   |        registered between 1961 and 1995 (Levi et al, 2001). Incidence
 75   II,     5. 11.  3   |            2001).~Between 1978 and 1995, the Slovakian Cancer Registry
 76   II,     5. 11.  7   | Berth-Jones J, Kurinczuk JJ et al (1995): prevalence of atopic dermatitis
 77   II,     5. 11.  7   |           variation. Br J Dermatol 1995;132:772-7.~ ~National Institute
 78   II,     5. 11.  7   |          cancer in Slovakia, (19781995). Neoplasma (2000):47:137–
 79   II,     5. 11.  7   |     Pembroke AC, Forsdyke H et al (1995): London-born black Carriben
 80   II,     5. 11.  7   |     dermatitis. J Am Acad Dermatol 1995;32:212-217.~ ~Williams HC (
 81   II,     6.  2       |            on trends for the years 199520041. This information
 82   II,     6.  3.  1   |         Summary of general trends (19952005), EU incidence (2005),
 83   II,     6.  3.  3   |           has been declining since 1995, when the AIDS incidence
 84   II,     6.  3.  3   |  increasing trends over the period 19952004 were observed in the
 85   II,     6.  3.  3   |            per 100 000 per year in 1995, to below 40 per 100 000
 86   II,     6.  3.  3   |          has been decreasing since 1995, while in the UK, Belgium
 87   II,     6.  3.  3   |          Gonorrhoea within the EU, 1995 - 2004~ ~Syphilis~ ~Syphilis
 88   II,     6.  3.  3   |            per 100 000 per year in 1995), a sharp decrease in incidence
 89   II,     6.  3.  3   |    relatively stable period during 19952000, the incidence in Europe
 90   II,     6.  3.  4   |           A1.2 Cases of TB between 1995 and 2004~ ~ ~ ~Table 6.A1.
 91   II,     6.  3.  4   |            Trends of legionellosis 1995 - 2004.~ ~The incidence
 92   II,     6.  3.  5   |      decrease was observed between 1995 and 2000, but after 2002,
 93   II,     6.  3.  5   |  preventable by vaccination. Since 1995, the Baltic countries, in
 94   II,     6.  3.  5   |      incidence in Latvia peaked in 1995 (15 per 100 000 per year)
 95   II,     6.  3.  5   |        Lithuania the incidences in 1995 were about one tenth of
 96   II,     6.  3.  5   |          for Italy and Portugal in 1995. In the new Member States,
 97   II,     6.  3.  5   |            trend in Europe between 1995 - 2004.~ ~This drop is mainly
 98   II,     6.  3.  5   |         Estonia in 1998, France in 199596, Italy in 1995–96 and
 99   II,     6.  3.  5   |        France in 1995–96, Italy in 199596 and 19992000, Latvia
100   II,     6.  3.  5   |          and 2002, in Lithuania in 1995 and 19992000, Czech Republic
101   II,     6.  3.  6   |         trend from 85 000 cases in 1995, to 180 000190 000 more
102   II,     6.  3.  6   |  Campylobacteriosis trends between 1995 - 2004~ ~In 2005, more than
103   II,     6.  3.  6   | contaminated food. After a peak in 1995, the incidence of salmonellosis
104   II,     6.  3.  6   |           steadily declining since 1995. The highest proportion (
105   II,     6.  3.  6   |          reported by Italy between 1995 and 2004 (6 440 cases).
106   II,     6.  3.  6   |          than doubled, rising from 1995 to 2002 and levelling off
107   II,     6.  3.  6   |           Europe decreased between 1995 and 1998, but since then
108   II,     6.  3.  6   |            was similar to that for 1995. Twenty-six countries reported
109   II,     6.  3.  6   |         reported in Europe between 1995 and 2004, and during this
110   II,     6.  3.  6   |      highest incidence observed in 1995 (1.68 per 100 000 per year),
111   II,     6.  3.  6   |         blood transfusion.~ ~Since 1995, vCJD has been detected
112   II,     6.  3.  7   |           the EU during the period 19952004, ranging from 0.1 to
113   II,     6.  3.  7   |          travellershealth.~Since 1995, France has accounted for
114   II,     7.  3.  2   |          Standardised Death Rates (1995-2004, Index = 1995), EU27~ ~
115   II,     7.  3.  2   |          Rates (1995-2004, Index = 1995), EU27~ ~
116   II,     8.  2.  2   |         blindness was published in 1995 (Thylefors et al, 1995).
117   II,     8.  2.  2   |          in 1995 (Thylefors et al, 1995). Since the publication
118   II,     8.  2.  2   |        Global Data on Blindness in 1995, several population-based
119   II,     8.  2.  2   |         World Health Organization. 1995;73(1):115-21.~WHO (2000):
120   II,     9           |        Brown, 2007a; Prysak et al, 1995). Parity is known to be
121   II,     9.  1.  1   |          HK, Alexander S, Berg CJ (1995) Maternal mortality in developed
122   II,     9.  1.  1   |            Obstetrics & Gynecology 1995;86(4 Pt 2):700-5.~ ~Bai
123   II,     9.  1.  1   |           MH, Varnoux N, Breart G (1995): Maternal deaths and substandard
124   II,     9.  1.  1   |         Obstet Gynecol Reprod Biol 1995;58(1):3-7.~ ~Breart G, Barros
125   II,     9.  1.  1   |         singleton gestations: USA, 1995-2000. J Matern Fetal Neonatal
126   II,     9.  1.  1   |      Prysak M, Lorenz RP, Kisly A (1995): Pregnancy outcome in nulliparous
127   II,     9.  1.  1   |          and older. Obstet Gynecol 1995;85(1):65-70.~Raymond EG,
128   II,     9.  1.  2   |        Brown, 2007a; Prysak et al, 1995). Parity is known to be
129   II,     9.  2.  7   |          mortality in Europe, 19551995. Eur J Cancer. 37:785-809.~ ~
130   II,     9.  3.  1   |            in female cases between 1995-97 (WHO, 2001). The health
131   II,     9.  3.  1   |            65 or over from 4.2% in 1995 to 9.5% in 2025. The most
132   II,     9.  3.  1   |       erectile dysfunction between 1995 and 2025 and some possible
133   II,     9.  3.  2   |         2001; Bouvier-Colle et al, 1995; Schuitmaker, 1998).~ ~The
134   II,     9.  3.  2   |   informant network (Atrash et al, 1995). Nonetheless, problems
135   II,     9.  3.  2   |          HK, Alexander S, Berg CJ (1995) Maternal mortality in developed
136   II,     9.  3.  2   |            Obstetrics & Gynecology 1995;86(4 Pt 2):700-5.~Bai J,
137   II,     9.  3.  2   |           MH, Varnoux N, Breart G (1995): Maternal deaths and substandard
138   II,     9.  3.  2   |         Obstet Gynecol Reprod Biol 1995;58(1):3-7.~ ~Breart G, Barros
139   II,     9.  3.  2   |         singleton gestations: USA, 1995-2000. J Matern Fetal Neonatal
140   II,     9.  3.  2   |      Prysak M, Lorenz RP, Kisly A (1995): Pregnancy outcome in nulliparous
141   II,     9.  3.  2   |          and older. Obstet Gynecol 1995;85(1):65-70.~ ~Raymond EG,
142   II,     9.  3.  3   |           20 quantitative studies (1995- May 2005) on individual
143   II,     9.  3.  3   |            in France (Bajos et al, 1995). In Portugal 4.2% of men
144   II,     9.  3.  3   |     Wellings K, Spira A, Field J. (1995): Sexual behaviour in HIV
145   II,     9.  4.  3   |           per cent in the UK since 1995. In the 65-plus age group
146   II,     9.  4.  3   |          150 to 416 cases, between 1995 and 2003, whilst cases of
147   II,     9.  5.  3   |        Lindstrand, 2006: Lindholm, 1995). Access to school sports
148   II,     9.  5.  6   |         Publications~ ~Lindholm G (1995): ÎSkolgrden, -vuxnas bilder -
149  III,    10.  1.  1   |     chronic diseases (Burke et al, 1995; Green and Potvin, 2004).
150  III,    10.  1.  3   |            Milligan R, Thompson C (1995): Assessment of nutrition
151  III,    10.  2.  1   |            school children between 1995 and 2003, with a more marked
152  III,    10.  2.  1   |            marked increase between 1995 and 1999 (Figure 10.2.3.
153  III,    10.  2.  1   |            around 73 000 (Farrell, 1995; EMCDDA, 2000). For countries
154  III,    10.  2.  1   |            at: htt ~ ~Farrell, M. (1995) Drug prevention: a review
155  III,    10.  2.  1   |        Health Education Authority, 1995). They are more likely to
156  III,    10.  2.  1   |        Health Education Authority (1995): Health update 5: physical activity.
157  III,    10.  2.  1   |          and fishery products from 1995 to 2002, whereas the average
158  III,    10.  2.  1   |            fishery products, EU15, 1995-2002 (1995=100)~ ~Figure
159  III,    10.  2.  1   |         products, EU15, 1995-2002 (1995=100)~ ~Figure 10.2.1.7.6.
160  III,    10.  3.  1   |            and mortality in Europe 1995. Eur. J. Cancer 38, 99-166.~
161  III,    10.  3.  2   |             and GDP by 25% between 1995 and 2005 (Figure 10.3.2.
162  III,    10.  3.  2   |           GDP for EU Member States 19952005~ ~Figure 10.3.2.3.
163  III,    10.  3.  3   |         Summary of general trends (19952005), main age groups affected (
164  III,    10.  3.  4   |       Union during the period from 1995 to 2006. The most important
165  III,    10.  4.  2   |             2003;~Salleras et al., 1995~ ~ ~Process contaminants~ ~
166  III,    10.  4.  2   |        lead-free petrol)~ ~ ~IPCS, 1995; De Hollander~et al., 1999~ ~
167  III,    10.  4.  2   |           regulations~ ~Episode in 1995 in Ireland~Monitoring~Van
168  III,    10.  4.  2   |            95/69/EC of 22 December 1995 laying down the conditions
169  III,    10.  4.  2   |               European Commission (1995): Decision No. 95/69/EC
170  III,    10.  4.  2   |            95/69/EC of 22 December 1995 laying down the conditions
171  III,    10.  4.  2   | Communities No. L 332, 30 December 1995.~ ~European Commission (
172  III,    10.  4.  3   |           with a 20% increase from 1995 to 2003.~ ~Figure 10.4.3.
173  III,    10.  4.  5   |           treated in EuropeData 1995-2003contains statistics
174  III,    10.  5.  3   |     employment from 66 per cent in 1995 to 71 per cent in 2005 in
175  III,    10.  6.  1   |            been performed in 1990, 1995, 2000 and 2005, has collected
176   IV,    11.  1.  5   |        implications (Carter et al, 1995; Cheah, 1998). Also, if
177   IV,    11.  1.  5   |      events (81.8%) (Wilson et al, 1995). Less research has been
178   IV,    11.  2.  2   |           total health spending in 1995 to 2% in 2005), and the
179   IV,    11.  3.  2   |            2.5 in Austria (between 1995 and 2005), 3.8 in Belgium,
180   IV,    11.  6.  2   |   responsiveness (Jones and Duncan 1995) and may be less susceptible
181   IV,    11.  6.  3   |           impact (Evans and Barer, 1995; Creese, 1997). Furthermore,
182   IV,    11.  6.  5   |            AO, Battista RN et al. (1995): "Proceedings of the 1994
183   IV,    11.  6.  5   |          46.~ ~Evans RG, Barer ML (1995): "User fees for health
184   IV,    11.  6.  5   |            4.~ ~Jones A, Duncan A (1995): Hypothecated taxation:
185   IV,    11.  6.  5   |           RM, Runciman WB et al., (1995): "The quality in Australian
186   IV,    12.  4       |       London, UK) - Established in 1995~http eu~To foster scientific
187   IV,    12.  5       |      consider a gain of 5% between 1995 and 2001 to signify compression
188   IV,    12.  8       |             France (1957)~Austria (1995)~Bulgaria (2007)~Italy (
189   IV,    12.  8       |         Luxemb0urg (1957)~Finland (1995)~Ireland (1973)~Hungary (
190   IV,    12.  8       |         1981)~Malta (2004)~Sweden (1995)~Spain (1986)~Netherlands (
191   IV,    12. 10       |            regulations~S.I. 135 of 1995 - import and export of certain
192   IV,    12. 10       |            Presidential Degree 105/1995Minimum standards for safety
193   IV,    13.Acr       |           total health spending in 1995 to 2% in 2004), and the
194   IV,    13.  7.  5   |     importance in this regard (EU, 1995).~ ~Article 8 of the Directive
195   IV,    13.  9       |               European Commission (1995): Directive 95/46/EC of
196   IV,    13.  9       |          Council of 24 October 168 1995 on the protection of individuals